ClinConnect ClinConnect Logo
Search / Trial NCT04662190

Evaluation of the Efficacy and Safety of 3D Printing for Orbital Surgery.

Launched by ALTHAIA XARXA ASSISTENCIAL UNIVERSITÀRIA DE MANRESA · Dec 6, 2020

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how 3D printing can help plan and simulate a specific type of eye surgery called orbital decompression surgery. This surgery is often needed for people with a condition known as thyroid-associated orbitopathy, which can cause swelling and pressure behind the eyes. The researchers want to see if using 3D printed models can improve the safety and effectiveness of the surgery.

To participate in this trial, you need to be over 18 years old and have a diagnosis of inactive thyroid-associated orbitopathy that requires surgery. You should also be able to read and agree to take part by signing a consent form. Unfortunately, if you have had previous eye surgery or other health issues that could interfere with follow-up care, you won’t be eligible. If you join the study, you can expect to be part of a process that may help improve surgical outcomes for future patients with similar conditions.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of inactive thyroid-associated orbitopathy requiring bilateral orbital decompression (moderate-severe in EUGOGO classification).
  • Volunteers older than 18 years old.
  • Ability to read.
  • Acceptation to participate and signature of informed consent.
  • Exclusion Criteria:
  • Younger than 18 years old.
  • Previous orbital surgery.
  • Any coexisting disease preventing follow-up.

About Althaia Xarxa Assistencial Universitària De Manresa

Althaia Xarxa Assistencial Universitària de Manresa is a leading healthcare institution in Catalonia, Spain, dedicated to providing high-quality medical care and advancing clinical research. As a university-affiliated network, Althaia integrates comprehensive healthcare services with academic excellence, fostering innovation and collaboration in the medical field. The organization is committed to improving patient outcomes through rigorous clinical trials and research initiatives, focusing on a wide range of therapeutic areas. With a multidisciplinary team of healthcare professionals, Althaia plays a pivotal role in enhancing evidence-based practices and contributing to the global medical community.

Locations

Manresa, Barcelona, Spain

Patients applied

0 patients applied

Trial Officials

Eduard Pedemonte-Sarrias, Md, PhD

Principal Investigator

Althaia Xarxa Assistencial Universitària de Manresa

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials